Health

Covishield and Covaxin Mixture? Clinical trial starts after approval from DCGI.

Jigar Saraswat

Published on August 11, 2021

Comment

Key takeaways from the article:

Covaxin and Covishield mix dose.
Will we see “COVshieldXin.”
A new experiment by DCGI (DRUG CONTROLLER GENERAL OF INDIA).
Clinical trial in Vellore Medical College.

Here we go, a new twist in corona vaccines in India. Now we will see mixed doses of Covishield and Covaxin. It would be like “COVshieldXin.”

What will be the name of Mix vaccines in India of first and second dose?: Surely, if trials become successful, we will get one more option to fight against COVID-19. The name of the mixed vaccine should be kept as “COVshieldXin.”

Mix dose experiment results are positive: According to top news sources, the trials were done in Vellore Medical College, and the results are very positive. The study was conducted in Uttar Pradesh, where people were doses of vaccines. The first vaccine of Covidshield, and the second of Covaxin. The average age of this test was 62.

You can also read Johnson and Johnson apply for approval in India for vaccine.

SOURCE FROM ANI

Related Topics:covaxin, Covishield, dcgi approval, expriment, India

Jigar Saraswat

Jigar Joshi, widely famous as Jigar Saraswat is an Indian content writer, Author, Blogger, Senior Editor working from 2015-16 in this vast field of Digital Marketing, PR, Content marketing. He has been providing Content writing services like Article writing, Press release writing, Blog writing, Website writing services etc for many years.